News | March 13, 2012

Accelitech Expands into Europe, Partners to Create First CyberKnife Center in Ireland

March 6, 2012 – Accelitech and partners have just completed a transaction to bring the first and only
CyberKnife stereotactic radiosurgery system to the Republic of Ireland. Scheduled to begin treating
patients in fall of 2012, the center will open on the campus of the Hermitage Medical Clinic in Dublin.

The partnership includes the following parties: Accelitech (lead developer), Neurosurgery Ireland (a
prominent Irish neurosurgical group), Regent Surgical Health (a developer of high-end specialized
surgical programs), the Hermitage Medical Clinic and several other local providers, all of whom share
the vision and interest in bringing this state-of-the-art cancer treatment technology to the people of
Ireland.

Historically, Irish patients requiring CyberKnife radiosurgery treatments—and in many cases their
treating neurosurgeons — have been required to travel to other countries to complete treatments.

"This partnership is a big win for the people of Ireland," says Scott Milligan, chief development officer
for Accelitech. "The new CyberKnife program will combine the very best clinical teams in the country
with the latest advanced technology in a conveniently located, patient-focused facility."

For more information: www.accelitech.biz

Related Content

RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
Overlay Init